Dry Eye in Delhi

MDS Therma Eye Plus is a medical-grade IPL system specifically designed and calibrated for ophthalmic dry eye use — not a generic dermatological device. It delivers controlled pulses of 530–1200 nm broad-spectrum light at a standardised energy of 8 J/cm² to the periocular skin, specifically targeting meibomian gland dysfunction through 7 simultaneous biological mechanisms. Unlike regular IPL used in beauty clinics, it has been clinically validated in peer-reviewed ophthalmic studies (PMC 2021) and is safe for all skin types including darker Indian skin tones (Fitzpatrick V–VI).

No — the procedure is well-tolerated by the vast majority of patients. You will feel brief flashes of warmth and see flashes of bright light through the closed eyelids (which are protected by opaque eye shields). Some patients with sensitive periocular skin report mild stinging during the pulse — this resolves immediately. There is no pain during or after the session, and no anaesthesia is required. Most patients are surprised by how quick and comfortable each session is.

The standard evidence-based protocol for Therma Eye Plus is 4 sessions: Day 1, Day 14, Day 28, and Day 49. This mirrors the protocol used in the landmark clinical study (Marques et al., PMC 2021). Most patients begin to notice symptom improvement after the second session. Some patients with mild MGD may achieve meaningful relief in 3 sessions; those with severe or long-standing MGD may benefit from an additional maintenance session. After the loading course, maintenance sessions every 6–12 months are recommended to sustain gland health.

The best candidates are patients with chronic dry eye symptoms (burning, grittiness, watering, blurred vision) that have not adequately responded to artificial tears, warm compresses, or lid hygiene — especially those with confirmed meibomian gland dysfunction on clinical assessment. IPL is particularly effective for patients with rosacea-associated dry eye, post-LASIK dry eye, contact lens intolerance due to dryness, and digital eye strain. Patients of all age groups and all Fitzpatrick skin types I–VI are suitable.

Contraindications include: active ocular infection or severe surface disease; open wounds, recent surgery, or active acne rosacea flare in the treatment area; history of photo-sensitising medications (e.g., tetracyclines, isotretinoin — discuss with your doctor); known photosensitivity disorders; recent sun tanning or sunburn in the treatment area; patients with a pacemaker (theoretical concern with any electrical/light device near the body); and pregnancy (out of caution, not specific contraindication). Darker pigmented lesions (nevi) in the treatment zone are covered with protective tape before each session.

Therma Eye Plus IPL is highly effective at treating the meibomian gland dysfunction component of dry eye — which is responsible for approximately 85% of all dry eye cases. For most patients with evaporative dry eye from MGD, IPL produces meaningful, lasting relief. However, dry eye is often a chronic condition with multiple contributing factors. IPL addresses MGD — but aqueous deficiency, environmental factors, medications, and autoimmune conditions may also need to be managed in parallel. Maintenance sessions help sustain gland health over the long term.

Yes — one of the key advantages of MDS Therma Eye Plus over many other IPL devices is its proven safety across all Fitzpatrick skin types, including V and VI — the skin tones common in Indian patients. The published clinical study (Marques et al., PMC 2021) specifically included patients of all skin types including darkest Indian skin tones, and reported no adverse events related to skin type. This is clinically important, as some IPL devices are associated with post-inflammatory hyperpigmentation in darker skin — Therma Eye Plus was designed to avoid this.

MDS Therma Eye Plus IPL therapy is priced at ₹7,000 per session for both eyes at Netram Eye Foundation, Greater Kailash II. The standard course of 4 sessions costs ₹28,000 in total. Maintenance sessions are ₹7,000 per session. The dry eye evaluation (NIBUT, OSDI, meibography) is included with your first consultation. There are no hidden charges. For patients who have responded well to 3 sessions, the 4th session can be deferred based on clinical reassessment.

Yes — you can use artificial tears and other prescribed drops immediately after each session. Contact lenses should be removed before the session and can be re-inserted 2–3 hours later once the cooling gel is fully removed and the ocular surface has settled. There are no activity restrictions after Therma Eye Plus sessions — you can drive, return to work, and use screens immediately. Avoid direct intense sunlight on the treated periocular skin for 24–48 hours after each session and use SPF sunscreen on the treated area.

LipiFlow (Johnson & Johnson) delivers heat and pressure from inside the eyelid (from the conjunctival surface) to directly express meibomian glands — it does not treat inflammation or telangiectasia. It is a single session device with strong evidence but is significantly more expensive. Therma Eye Plus IPL works from outside the eyelid (periocular skin), addressing not only gland warming but also inflammation, Demodex, and vascular changes — 7 mechanisms vs LipiFlow's primarily thermal/pressure approach. IPL has growing evidence for more durable relief than single thermal pulsation sessions. At Netram, we offer Therma Eye Plus IPL as our primary in-office dry eye treatment.

Published data from the Therma Eye Plus clinical study shows sustained improvement in OSDI, NIBUT, and meibomian gland function parameters at 4 months after the final session (23 weeks total from first session). Long-term durability is supported by real-world clinical experience — many patients maintain meaningful relief for 9–18 months after a 4-session course. Maintenance sessions every 6–12 months are recommended for patients with chronic MGD to sustain meibomian gland health and prevent relapse. Chronic dry eye is a long-term condition; IPL is an ongoing management tool, not a one-time cure.